FDA Warnings And Restrictions On JAKs Curb Growth Potential Of Big Brands

 
• By Jessica Merrill
  
Caution tape
FDA put new warnings on JAK inhibitors for inflammatory conditions • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapeutic Category